EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

KNOWLEDGE BANK

  • Articles

    The Architect of the Void: When 3D Printing Becomes the Body’s New Bone

    In the quiet pressurised hum of a modern surgical suite a surgeon holds a highdefinition scan of a young patients femur On the screen a jagged dark shadow marks where an osteosarcoma has claimed its territory For decades the script for this moment has been written in cold hard steel

    From Visibility to Decision Readiness: The Next Phase of Quality Maturity in Pharma

    Over the past decade pharmaceutical organisations have made strong progress in both digitising and digitalising quality operations Systems such as laboratory information management systems LIMS manufacturing execution systems MES and electronic quality management systems eQMS have strengthened traceability embedded workflows and enabled real time visibility across quality processes

    How Drug Patents Shape the Competitive Landscape in Pharma?

    It can rightly be said that the business of pharmaceuticals is very sensitive and crucial since business is all about the manufacturing of change for the purpose of ridding the world of diseases

    How Predictive Maintenance Reduces Downtime in Pharma Plants

    The pharmaceutical industry is always under stress to enhance the reliability of the production adherence to the regulations and quality of the products without raising the prices and to maintain a continuous supply Machinery malfunctions are not merely a setback in this highstakes game they may compromise batch integrity postpone life and death treatments and put pressure on the market promises

    Exploring the Benefits of Sustainable Clinical Trials

    The landscape of clinical trials is evolving with a growing recognition that research endeavors should extend beyond scientific excellence to encompass broader societal environmental and economic considerations

    How Mass Spectrometers Are Transforming the Study of Metabolomics

    The mechanism of metabolomics can be described as a relatively young science which is rather popular in modern science and investigates metabolites which are the small molecules that take part in the metabolic processes inside the living organism This discipline therefore has great potential as a tool in proactively unraveling a diverse range of biological occurrences disease processes or even tre...

TOP ARTICLES

  • 4

    Exploring the Benefits of Sustainable Clinical Trials

    Debi Jones

    Sustainable clinical trials signify a transformative shift in research, integrating scientific rigor with environmental responsibility, resource efficiency, and community engagement. This paradigm enh...

press releases Read more...

BioMed X Launches Innovation Circle at BIO International Convention 2026

BioMed X a buildtosolve innovation engine for pharma officially launched the BioMed X Innovation Circle during the BIO International Convention last week bringing together leaders from across the global

Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)

Novartis today announced that the European Commission EC has approved Itvisma onasemnogene abeparvovec for the treatment of children two years and older teens and adults living with q spinal muscular

Turkish Cargo has been Selected as the “Cargo Airline of the Year – Global” for the Second Consecutive Time

Turkish Airlines global air cargo brand Turkish Cargo was awarded Cargo Airline of the Year Global for the second consecutive time at the World Air Cargo Awards organized by Air Cargo Week

Lonza Expands HPAPI Capacity in Visp, Further Supporting its Position in Payload-Linker Manufacturing

Lonza the worlds leading contract development and manufacturing organization CDMO today announced plans to enhance its druglinker center of excellence and expand payloadlinker manufacturing capacity at its Visp site

07 - 09

Jul 2026

The Pharma India Expo 2026

Bombay Exhibition Centre, Mumb...

07 - 09

Jul 2026

08 - 10

Jul 2026

CPHI SEA 2026

QSNCC, Bangkok, Thailand

09 - 11

Jul 2026

Pharma Pro&Pack Expo 2026

HITEX Exhibition Centre, Hyder...

16 - 19

Jul 2026

Bio Asia Taiwan 2026

Taipei Nangang Exhibition Cent...

20 - 22

Jul 2026

6th mRNA-Based Therapeutics Summit

The Westin Boston Seaport Dist...

20 - 22

Jul 2026

24 - 25

Jul 2026

LATEST NEWS Read more...

Nona Biosciences and Lonza Collaborate on BBB-Crossing Technology for CNS Drug Development

Nona Biosciences has entered into a strategic collaboration with Lonza to develop singledomain antibodybased bloodbrain barrier BBBcrossing technology for the treatment of central nervous system CNS diseases

Vertex Secures US FDA Approval for Expanded Use of CASGEVY in Young Children

Vertex Pharmaceuticals has received approval from the US Food and Drug Administration FDA to expand the use of CASGEVY exagamglogene autotemcel for patients aged two years and older with sickle cell disease

Ipsen to acquire Kartos Therapeutics to strengthen late-stage haemato-oncology pipeline

Ipsen has entered into a definitive merger agreement to acquire Kartos Therapeutics adding the investigational MDM inhibitor navtemadlin to its latestage haematooncology pipeline

AstraZeneca and YMCA of the USA Partner to Expand Cancer Education and Support Services

AstraZeneca and YMCA of the USA YUSA have announced a fiveyear partnership aimed at improving cancer education increasing awareness of screening and early detection and expanding support programmes for cancer survivors

Merck Partners with Saturnus Bio to Develop Treatments for Rare Genetic Cardiomyopathies

Merck has entered into a strategic researchstage collaboration with Saturnus Bio a biotechnology company founded by Versant Ventures to build a portfolio of therapies for rare genetic cardiomyopathies

Quoin Receives FDA Conditional Approval for QYLEKI Brand Name for Netherton Syndrome Therapy

Quoin Pharmaceuticals has received conditional approval from the US Food and Drug Administration FDA for QYLEKI as the proposed brand name of QRX its investigational treatment for Netherton Syndrome